Following expert panel guidelines, the Centre approved extending the time between the first and second doses of the Covishield vaccine to 12-16 weeks on Thursday. The time between two vaccine doses is currently 6-8 weeks.
The National Technical Advisory Group on Immunization had recommended the same to the Centre earlier in the day. The interval, on the other hand, for Covaxin has remained unchanged.
Pregnant women may select their vaccine, and lactating women would be eligible after delivery, according to the panel. Neither of them is currently qualified for the shots.
According to the panel, the panel also recommended delaying Covid-19 vaccination for six months after recovering from SARS-CoV-2 infection. According to the Union Health Ministry’s current policy, the vaccine should be given four to eight weeks after recovery from the Covid-19 infection, and it should not be given to pregnant or lactating mothers. Before being enforced, these guidelines will be submitted to NEGVA (National Expert Group on Vaccine Administration) for approval.
“The Covid-19 working group decided to increase the dosing period between two doses of Covishield vaccine to 12-16 weeks based on available real-world evidence, especially from the United Kingdom. According to PTI sources, “no improvement in the interval of Covaxin vaccine doses was recommended.”